[Complex drug therapy of patients with juvenile uterine hemorrhage dependent on the status of the hemostasis system].
The authors analyze the results of examinations and treatment of 125 patients, suffering from juvenile uterine bleedings, divided into three age groups and subgroups with different status of the hemostasis. They consider the suggested complex of drug therapy as an additional diagnostic test for the detection of the underlying pathogenetic component of such bleedings and recommend a pathogenetically-based hemostasis and adequate therapy to regulate menstrual function.
Kuznetsova
M N
MN
Saidova
R A
RA
D000293:Adolescent; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000150:complications; D002125:Calcium Gluconate / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005831:Genital Diseases, Female / Q000150:complications; D005938:Glucocorticoids / Q000627:therapeutic use*; D006487:Hemostasis; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy* / Q000209:etiology; D011627:Puberty
D005938:Glucocorticoids; D001205:Ascorbic Acid; D002125:Calcium Gluconate
Kompleksnaia medikamentoznaia terapiia bol'nykh s iuvenil'nymi matochnymi krovotecheniiami v zavisimosti ot sostoianiia sistemy gemostaza.